Otonomy (OTIC) Announces Proposed Public Offering

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that it has commenced an underwritten public offering of its common stock. All shares of common stock to be sold in the offering will be offered by Otonomy. Otonomy may, in lieu of common stock, offer and sell to certain investors pre-funded warrants to purchase shares of its common stock in the underwritten public offering. In addition, Otonomy expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in this public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Cowen and Piper Sandler are acting as joint book-running managers in the offering.

You May Also Be Interested In

• Universe Pharmaceuticals (UPC) Files for 20M Share Offering by Selling Stockholders
• Texas Instruments (TXN) PT Raised to $175 at TD Cowen
• JetBlue Airways (JBLU) PT Lowered to $6 at TD Cowen